CLINICAL_TRIALS
trial_result
· 2014-02-17
Clinical Trial Update: Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir [Phase 1]
Summary
Phase 1 trial update evaluating multiple doses of TMC647055 in combination with telaprevir for Hepatitis C has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen R&D Ireland | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED